With four decades of company-building, IPOs, boardroom leadership, and monumental exits behind him, Raymond W. Cohen has become one of medtech’s most successful operators. But behind the financial wins — including the recent back-to-back $3.7 billion Axonics and $600 million SoniVie acquisitions by Boston Scientific — is a deeper story of Cohen’s contrarian, full-transparency, people-centered, no-BS approach to leadership and strategy. This blog is originally published here: https://www.lifesciencemarketresearch.com/insights/cover-story-a-page-from-ray-cohens-playbook-scaling-exiting-and-winning-in-medtech